Kosloski M, Pisal D, Mager D, Balu-Iyer S
J Pharm Sci. 2013; 102(7):2380-94.
PMID: 23620343
PMC: 3676521.
DOI: 10.1002/jps.23566.
Czock D, Giehl M, Keller F
Clin Pharmacokinet. 2000; 38(4):367-75.
PMID: 10803457
DOI: 10.2165/00003088-200038040-00005.
Hernadez R, Igartua M, Gascon A, Calvo M, Pedraz J
Eur J Drug Metab Pharmacokinet. 1998; 23(2):92-6.
PMID: 9725463
DOI: 10.1007/BF03189321.
Steimer J, Ebelin M, van Bree J
Eur J Drug Metab Pharmacokinet. 1993; 18(1):61-76.
PMID: 8335040
DOI: 10.1007/BF03220009.
Francheteau P, Steimer J, Merdjan H, GUERRET M, Dubray C
J Pharmacokinet Biopharm. 1993; 21(5):489-514.
PMID: 8145128
DOI: 10.1007/BF01059111.
Transdermal administration of morphine to healthy subjects.
Westerling D, Hoglund P, Lundin S, Svedman P
Br J Clin Pharmacol. 1994; 37(6):571-6.
PMID: 7917776
PMC: 1364817.
DOI: 10.1111/j.1365-2125.1994.tb04306.x.
Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial.
Montes B, Catalan M, Roces A, Jeanniot J, Honorato J
Eur J Clin Pharmacol. 1993; 45(2):169-72.
PMID: 7901024
DOI: 10.1007/BF00315501.
Plasma and red blood cell pharmacokinetics of pimobendan enantiomers in healthy Chinese.
Chu K, Shieh S, Hu O
Eur J Clin Pharmacol. 1995; 47(6):537-42.
PMID: 7768258
DOI: 10.1007/BF00193708.
Pharmacokinetics of A40926 in rats after single intravenous and subcutaneous doses.
Bernareggi A, Danese A, Cavenaghi L
Antimicrob Agents Chemother. 1988; 32(2):246-9.
PMID: 3364946
PMC: 172143.
DOI: 10.1128/AAC.32.2.246.
PharmCalc: program for the calculation of clinical pharmacokinetic parameters of methotrexate.
Borsi J, Klepp O, MOE P
Cancer Chemother Pharmacol. 1988; 22(4):339-43.
PMID: 3168146
DOI: 10.1007/BF00254242.
Pharmacokinetics of teicoplanin in pediatric patients.
Terragna A, Ferrea G, Loy A, Danese A, Bernareggi A, Cavenaghi L
Antimicrob Agents Chemother. 1988; 32(8):1223-6.
PMID: 2973284
PMC: 172381.
DOI: 10.1128/AAC.32.8.1223.
Pharmacokinetic and nephrotoxic study of gentamicin in rabbits using a new dosage regimen.
Trapote M, Arevalo M, Lanao J, Macias M, Navarro A, Alonso M
Eur J Drug Metab Pharmacokinet. 1989; 14(2):169-75.
PMID: 2591422
DOI: 10.1007/BF03190858.
A phase I and pharmacokinetic study of intravenous vinzolidine.
Taylor C, Salmon S, Satterlee W, Robertone A, McCloskey T, Holdsworth M
Invest New Drugs. 1990; 8 Suppl 1:S51-7.
PMID: 2380017
DOI: 10.1007/BF00171984.
Clinical pharmacokinetics of intravenously injected tritiated vinzolidine.
Kreis W, Budman D, Freeman J, Bergstrom R, Nelson R
Cancer Chemother Pharmacol. 1990; 26(6):419-22.
PMID: 2225313
DOI: 10.1007/BF02994092.
Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses.
Del Favero A, Patoia L, Rosina R, BUNIVA G, Danese A, Bernareggi A
Antimicrob Agents Chemother. 1991; 35(12):2551-7.
PMID: 1839759
PMC: 245429.
DOI: 10.1128/AAC.35.12.2551.
Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease.
Halstenson C, WONG M, Herman C, Teal M, Affrime M, Kelloway J
Antimicrob Agents Chemother. 1992; 36(9):1832-6.
PMID: 1416875
PMC: 192195.
DOI: 10.1128/AAC.36.9.1832.